Antioxidant supplements for liver diseases.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  2011-03-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD007749.pub2PMID 21412909PMCID PMC12501834
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathophysiological Basis for Antioxidant Therapy in Chronic Liver Disease

  2012cited by this paper
• Ribavirin plus interferon versus interferon for chronic hepatitis C.

  2010cited by this paper
• Ribavirin plus interferon versus interferon for chronic hepatitis C.

  2010cited by this paper
• Evidence at a glance: error matrix approach for overviewing available evidence

  2010cited by this paper
• Antioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C.

  2010cited by this paper
• Adverse events in randomized trials: neglected, restricted, distorted, and silenced.

  2009cited by this paper
• Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?

  2009cited by this paper
• Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses.

  2009cited by this paper
• Bmc Medical Research Methodology Open Access Estimating Required Information Size by Quantifying Diversity in Random-effects Model Meta-analyses

  2009cited by this paper
• Systematic Review and Meta-analysis Supplements for Primary and Secondary Prevention: Mortality in Randomized Trials of Antioxidant

  2009cited by this paper
• Systematic review: primary and secondary prevention of gastrointestinal cancers with antioxidant supplements

  2008cited by this paper
• Oxidative mechanisms in the pathogenesis of alcoholic liver disease.

  2008cited by this paper
• Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

  2008cited by this paper
• Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis.

  2008cited by this paper
• Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses.

  2008cited by this paper
• Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.

  2007cited by this paper
• Oxidative‐inflammatory damage in cirrhosis: Effect of vitamin E and a fermented papaya preparation

  2007cited by this paper
• Relationship between Funding Source and Conclusion among Nutrition-Related Scientific Articles

  2007cited by this paper
• Antioxidant therapy for chronic hepatitis C after failure of interferon: results of phase II randomized, double-blind placebo controlled clinical trial.

  2007cited by this paper
• Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis.

  2007cited by this paper
• Hepatology may have problems with putative surrogate outcome measures.

  2007cited by this paper
• Much ado about nothing: a comparison of the performance of meta‐analytical methods with rare events

  2007cited by this paper
• Association between unreported outcomes and effect size estimates in Cochrane meta-analyses.

  2007cited by this paper
• Does oxidative stress participate in the development of hepatocellular carcinoma?

  2007cited by this paper
• Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong

  2007cited by this paper
• Publication bias against negative results from clinical trials: three of the seven deadly sins

  2007cited by this paper
• A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis.

  2007cited by this paper
• Low selenium status in alcoholic cirrhosis is correlated with aminopyrine breath test

  2007cited by this paper
• Alpha-tocopherol [corrected] and ascorbic acid attenuates the ribavirin [corrected] induced decrease of eicosapentaenoic acid in erythrocyte membrane in chronic hepatitis C patients.

  2006cited by this paper
• Surrogate markers in clinical studies: problems solved or created?

  2006cited by this paper
• Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension

  2006cited by this paper
• Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis.

  2006cited by this paper
• The culture of designing hepato-biliary randomised trials.

  2006cited by this paper
• Vitamin E and C supplementation prevents decrease of eicosapentaenoic acid in mononuclear cells in chronic hepatitis C patients during combination therapy of interferon alpha-2b and ribavirin.

  2006cited by this paper
• Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial.

  2006cited by this paper
• 417–2α‐Tocopherol and ascorbic acid attenuates the ribavirin‐induced decrease of eicosapentaenoic acid in erythrocyte membrane in chronic hepatitis C patients

  2006cited by this paper
• S-adenosyl-L-methionine for alcoholic liver diseases.

  2006cited by this paper
• The effect of antioxidant supplementation on hepatitis C viral load, transaminases and oxidative status: a randomized trial among chronic hepatitis C virus-infected patients

  2006cited by this paper
• Bias in clinical intervention research.

  2006cited by this paper
• Publication Bias: Recognizing the Problem, Understanding Its Origins and Scope, and Preventing Harm

  2006cited by this paper
• Randomized trials stopped early for benefit: a systematic review.

  2005cited by this paper
• Vitamin E-based therapy is effective in ameliorating transaminasemia in nonalcoholic fatty liver disease.

  2005cited by this paper
• Treatment of Chronic Hepatitis C Virus Infection via Antioxidants: Results of a Phase I Clinical Trial

  2005cited by this paper
• Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors

  2005cited by this paper
• A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease

  2005cited by this paper
• Outcome selection bias in meta-analysis

  2005cited by this paper
• Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment.

  2005cited by this paper
• Review article: role of oxidative stress in the progression of non‐alcoholic steatosis

  2005cited by this paper
• LIVER FAILURE AND LIVER DISEASE

  2005cited by this paper
• What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data.

  2004cited by this paper
• A randomized placebo controlled trial of vitamin E for alcoholic hepatitis.

  2004cited by this paper
• Pilot study on the effect of parenteral vitamin E on ischemia and reperfusion induced liver injury: a double blind, randomized, placebo-controlled trial.

  2004cited by this paper
• Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.

  2004cited by this paper
• High‐dose vitamin E supplementation does not diminish ribavirin‐associated haemolysis in hepatitis C treatment with combination standard α‐interferon and ribavirin

  2004cited by this paper
• Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research

  2004cited by this paper
• The Role of Vitamin E and C Therapy in NASH

  2004cited by this paper
• The Food Standards Agency's antioxidants in food programme--a summary.

  2003cited by this paper
• Effect of Vitamin E on Serum Aminotransferase and Thioredoxin Levels in Patients with Viral Hepatitis C

  2003cited by this paper
• Routine Vitamin Supplementation To Prevent Cardiovascular Disease: A Summary of the Evidence for the U.S. Preventive Services Task Force

  2003cited by this paper
• Routine Vitamin Supplementation To Prevent Cancer and Cardiovascular Disease: Recommendations and Rationale

  2003cited by this paper
• Analysis and reporting of factorial trials: a systematic review.

  2003cited by this paper
• Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: results of a multicentre, randomized, placebo‐controlled, cross‐over trial

  2003cited by this paper
• Changes in Serum Retinol, α-Tocopherol, Vitamin C, Carotenoids, Zinc and Selenium after Micronutrient Supplementation during Alcohol Rehabilitation

  2003cited by this paper
• LITERATURE SEARCHING FOR RANDOMIZED CONTROLLED TRIALS USED IN COCHRANE REVIEWS: RAPID VERSUS EXHAUSTIVE SEARCHES

  2003cited by this paper
• Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E

  2003cited by this paper
• Interaction revisited: the difference between two estimates

  2003cited by this paper
• Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis

  2003cited by this paper
• Routine vitamin supplementation to prevent cancer and cardiovascular disease: recommendations and rationale.

  2003cited by this paper
• Pilot clinical trial of the use of alpha-tocopherol for the prevention of hepatocellular carcinoma in patients with liver cirrhosis.

  2003cited by this paper
• Quantifying heterogeneity in a meta‐analysis

  2002cited by this paper
• Effects of alcohol and oxidative stress on liver pathology: the role of the mitochondrion.

  2002cited by this paper
• The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials

  2001cited by this paper
• S-adenosyl-L-methionine for alcoholic liver diseases.

  2001cited by this paper
• Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses

  2001cited by this paper
• Improvement of hemorheological abnormalities in alcoholics by an oral antioxidant.

  2001cited by this paper
• Plasma transforming growth factor‐β1 level and efficacy of α‐tocopherol in patients with non‐alcoholic steatohepatitis: a pilot study

  2001cited by this paper
• The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

  2001cited by this paper
• Does ascorbic acid prevent retinopathy during interferon therapy in patients with chronic hepatitis C?

  2001cited by this paper
• Vitamin E as treatment for chronic hepatitis B: results of a randomized controlled pilot trial.

  2001cited by this paper
• Pathogenesis of liver fibrosis: role of oxidative stress.

  2000cited by this paper
• Interferon/antioxidant combination therapy for chronic hepatitis C--a controlled pilot trial.

  1999cited by this paper
• HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Vitamin E Reduces Monocyte Tissue Factor Expression in Cirrhotic Patients

  1999cited by this paper
• Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not responsive to alpha-interferon alone: a randomized, multicentre study.

  1999cited by this paper
• Health effects of vegetables and fruit: assessing mechanisms of action in human experimental studies.

  1999cited by this paper
• Diagnosing Syncope

  1998cited by this paper
• Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

  1998cited by this paper
• Fruit and vegetables, and cardiovascular disease: a review.

  1997cited by this paper
• Oxidative damage and fibrogenesis.

  1997cited by this paper
• A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C.

  1997cited by this paper
• Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: a randomized, double-blind, placebo-controlled study.

  1997cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Vegetables, fruit, and cancer prevention: a review.

  1996cited by this paper
• Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.

  1995cited by this paper
• Effects of long-term vitamin E supplementation in alcoholic cirrhotics.

  1995cited by this paper
• Operating characteristics of a rank correlation test for publication bias.

  1994cited by this paper
• The effect of antioxidant supplementation on a serum marker of free radical activity and abnormal serum biochemistry in alcoholic patients admitted for detoxification.

  1993cited by this paper
• Liver damage due to free radicals.

  1993cited by this paper
• [Alcohol-induced toxic hepatitis--a "free radical" associated disease. Lowering fatality by adjuvant antioxidant therapy].

  1993cited by this paper
• Tissue thiamin levels of hospitalised alcoholics before and after oral or parenteral vitamins.

  1988cited by this paper
• Vitamin A treatment of sexual dysfunction in male alcoholics.

  1988cited by this paper

• Biological, anti-inflammatory and antioxidant activity of c-PEI based silica nano composites

  2024cites this paper
• Vitamin E for people with non‐alcoholic fatty liver disease

  2024cites this paper
• In Cochrane nutrition reviews assessment of dietary adherence varied considerably.

  2023cites this paper
• Effect of Selenium Deficiency on the Development of Overt Hepatic Encephalopathy in Patients with Chronic Liver Disease

  2023cites this paper
• Mitochondrial dysfunction: A promising therapeutic target for liver diseases

  2023cites this paper
• A Clinical Study of Spectrum of Liver Diseases in Alcoholic with Respect to Predictors of Severity and Prognosis

  2022cites this paper
• Phytochemical analysis and determination of antioxidant, anti-cholesterol, anti-inflammatory and anti-proliferative activities of Gerbera jamesonii flowers

  2022cites this paper
• Vitamin E for people with non-alcoholic fatty liver disease

  2022cites this paper
• Metabolic Disorders in Patients with Chronic Hepatitis B Virus Infection: Coffee as a Panacea? (ANRS CO22 Hepather Cohort)

  2022cites this paper
• Stimulation of de novo glutathione synthesis by nitrofurantoin for enhanced resilience of hepatocytes

  2021cites this paper
• Case Report: Extended Clinical Spectrum of the Neonatal Diabetes With Congenital Hypothyroidism Syndrome

  2021cites this paper
• Chronic liver diseases

  2021cites this paper
• Chemical composition and biological activities of aqueous extracts and their sulfated derivatives of pea peel (Pisum sativum L.)

  2021cites this paper
• New natural antioxidants

  2020cites this paper
• Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases

  2020cites this paper
• FETAL ALCOHOL SPECTRUM DISORDERS

  2020cites this paper
• Vitamin E

  2020cites this paper
• Convenient synthesis of new indeno[1,2-b]pyridine derivatives for antimicrobial and antioxidant evaluation

  2020cites this paper
• Poor chemical and microbiological quality of the commercial milk thistle-based dietary supplements may account for their reported unsatisfactory and non-reproducible clinical outcomes

  2019cites this paper
• Supplemental Antioxidants: A Hype in Disease Prevention.

  2019cites this paper
• Acute Alcoholic Hepatitis.

  2019cites this paper
• Functions and Applications of Bioactive Peptides From Corn Gluten Meal.

  2019cites this paper
• Sulforaphane: Its “Coming of Age” as a Clinically Relevant Nutraceutical in the Prevention and Treatment of Chronic Disease

  2019cites this paper
• Morphoquantitative effects of oral β-carotene supplementation on liver of C57BL/6 mice exposed to ethanol consumption.

  2019cites this paper
• p66Shc Contributes to Liver Fibrosis through the Regulation of Mitochondrial Reactive Oxygen Species

  2019cites this paper
• Diagnosis and Treatment of Alcohol-Related Liver Diseases

  2019cites this paper
• Laboratory tests commonly used in complementary and alternative medicine: a review of the evidence

  2019cites this paper
• Vitamin E Supplementation for Treatment of Statin Induced Hepatocellular Damage: A Randomized, Double-Blind, Placebo- Controlled Trial

  2018cites this paper
• Review and gap analysis: molecular pathways leading to fetal alcohol spectrum disorders

  2018cites this paper
• Trends in vitamin, mineral and dietary supplement use in Switzerland. The CoLaus study

  2017cites this paper
• Behaviors of consumers, physicians and pharmacists in response to adverse events associated with dietary supplement use

  2017cites this paper
• Investigation of the impact of blueberries on metabolic factors influencing health

  2017cites this paper
• Fetal alcohol spectrum disorders

  2017cites this paper
• An Antioxidant Combination Improves Histopathological Alterations and Biochemical Parameters in D-Galactosamine-Induced Hepatotoxicity in Rats

  2017cites this paper
• Dietary and metabolic modulators of hepatic immunity

  2017cites this paper
• Chemoprotective effect of omega-3 fatty acids on thioacetamide induced hepatic fibrosis in male rats

  2016cites this paper
• Vitamin E supplementation for adults with diabetes mellitus

  2016cites this paper
• Relationships among alcoholic liver disease, antioxidants, and antioxidant enzymes.

  2016cites this paper
• Acute Alcoholic Hepatitis: Therapy.

  2016cites this paper
• Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis.

  2016cites this paper
• Determining antioxidant activities of lactobacilli by cellular antioxidant assay in mammal cells

  2015cites this paper
• Dietary Supplement Use Among Patients With Hepatocellular Carcinoma

  2015cites this paper
• Concomitant Use of Dietary Supplements and Medicines in Patients due to Miscommunication with Physicians in Japan

  2015cites this paper
• Role of vitamins in gastrointestinal diseases.

  2015cites this paper
• Diet and upper gastrointestinal malignancies.

  2015cites this paper
• Angelica keiskei Koidzumi Extracts Improve Some Markers of Liver Function in Habitual Alcohol Drinkers: A Randomized Double-Blind Clinical Trial

  2015cites this paper
• Oxidative Stress in Autoimmune Liver Disease

  2015cites this paper
• Effect of hydrosoluble vitamin E on erythrocyte membrane lipid composition in patients with advanced cirrhosis: An open‐label pilot trial

  2015cites this paper
• NUTRIENTS AND GASTROINTESTINAL MALIGNANCIES Diet and Upper Gastrointestinal Malignancies

  2015cites this paper
• Alcoholic liver cirrhosis & herbs

  2015cites this paper
• Reactive Oxygen Species (ROS) and Liver Disease Therapy

  2014cites this paper
• Inappropriate Usage of Dietary Supplements in Patients by Miscommunication with Physicians in Japan

  2014cites this paper
• Oxidant Stress and Drug-Induced Hepatotoxicity

  2014cites this paper
• Mitigation of carbon tetrachloride‐induced hepatic injury by methylene blue, a repurposed drug, is mediated by dual inhibition of GSK3β downstream of PKA

  2014cites this paper
• Effects of α-tocopherol and β-carotene supplementation on liver cancer incidence and chronic liver disease mortality in the ATBC study

  2014cites this paper
• Association of serum α-tocopherol, β-carotene, and retinol with liver cancer incidence and chronic liver disease mortality

  2014cites this paper
• Systematic Review with Meta-Analysis Effect of plant foods and beverages on plasma non-enzymatic antioxidant capacity in human subjects: a meta-analysis

  2013cites this paper
• Investigating the effect of aspalathus linearis as a cardio-protective therapy in isolated rat cardiomyocytes

  2013cites this paper
• Selenium-Enriched Fatty Goose Liver Attenuates Alcohol-Induced Liver Injury in Mice by Enhancing Antioxidant Capability

  2013cites this paper
• Thought-provoking Molecules for Drug Discovery: antioxidants

  2013cites this paper
• Patterns of histone acetylation as targets for novel therapeutic approaches in neurological diseases

  2013cites this paper
• Oxidative status interactome map: towards novel approaches in experiment planning, data analysis, diagnostics and therapy.

  2013cites this paper
• Vitamin C as well as β-carotene attenuates experimental liver fibrosis after intoxication with carbon tetrachloride in rats

  2012cites this paper
• Natural polyphenols against neurodegenerative disorders: potentials and pitfalls.

  2012cites this paper
• NUTRITIVE THERAPY OF HEPATIC ENCEPHALOPATHY AS A COMPLICATION OF LIVER CIRRHOSIS

  2012cites this paper
• Papel de los antioxidantes en la prevención del cáncer

  2012cites this paper
• Suppression of the Hepatitis C viral load by Phyllanthus niruri extracts

  2012cites this paper
• Aqueous Extract of Tulsi (Ocimum sanctum) Enhances Endogenous Antioxidant Defenses of Human Hepatoma Cell Line (HepG2)

  2012cites this paper
• Bilberry and blueberry anthocyanins act as powerful intracellular antioxidants in mammalian cells.

  2012cites this paper
• Corn oligopeptides protect against early alcoholic liver injury in rats.

  2012cites this paper
• Glutathione Redox Control of Asthma: From Molecular Mechanisms to Therapeutic Opportunities

  2012cites this paper
• Melatonin: The smart killer The human trophoblast as a model

  2012cites this paper
• Biochemical changes in inborn and acquired errors of metabolism

  2012cites this paper
• Effect of Flavonoid Quercetin Supplement on the Progress of Liver Cirrhosis in Rats

  2011cites this paper
• Antioxidantes en Gastroenterología

  2011cites this paper
• Antioxidant Supplementation for Liver Disease

  2011cites this paper
• Alcoholic liver disease, oxidative stress, and antioxidants.

  2011cites this paper
• Meta‐analysis: antioxidant supplements for liver diseases – the Cochrane Hepato‐Biliary Group

  2010cites this paper